Heidelberg, Germany

Sonja Krösser

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 4.2

ph-index = 3

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2022-2024

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Sonja Krösser: Innovator in Ophthalmic Treatments

Introduction

Sonja Krösser is a prominent inventor based in Heidelberg, Germany. She has made significant contributions to the field of ophthalmology, particularly in the treatment of dry eye disease. With a total of four patents to her name, Krösser's work is paving the way for innovative solutions in eye care.

Latest Patents

Among her latest patents is an ophthalmic composition for the treatment of dry eye disease. This invention provides ophthalmic compositions comprising about 0.1% (w/v) cyclosporine dissolved in 1-(perfluorobutyl)pentane for use in the topical treatment of dry eye disease. It also includes treatment methods and kits comprising such compositions. Another notable patent involves ophthalmic compositions comprising F6H8. This disclosure provides methods of treatment using these compositions for keratoconjunctivitis sicca and/or Meibomian gland dysfunction. The methods focus on enriching ophthalmic tissue with the semifluorinated alkane and include options for delayed release from the enriched tissue to the surface of the cornea and/or conjunctiva, and/or to the Meibomian gland.

Career Highlights

Sonja Krösser is currently employed at Novaliq GmbH, where she continues to develop innovative ophthalmic solutions. Her work is characterized by a commitment to improving patient outcomes through advanced research and development.

Collaborations

Some of her notable coworkers include Thomas Schlüter and Chiara Silvana Leo, who contribute to the collaborative environment at Novaliq GmbH.

Conclusion

Sonja Krösser's innovative work in ophthalmic treatments exemplifies her dedication to advancing eye care. Her patents reflect a deep understanding of the complexities of eye diseases and a commitment to finding effective solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…